Our Partners

The High Precision Biomarker Discovery Platform was established through a partnership between scientists and clinicians at Monash University, the Hudson Institute of Medical Research, The Walter and Eliza Hall of Medical Research, the University of Tasmania, Flinders University, as well as commercial biotechnology company Diag-NOSE, and is supported by funding from Monash University and the Medical Research Future Fund (MRFF) though the National Critical Research Infrastructure (NCRI) initiative provided by the Australian Government. We gratefully acknowledge their financial support, which made this platform possible.